Lupus Nephritis
📧 Sign up to get email alerts when something new happens for Lupus Nephritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-02-27Clinical Trial Update: A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis [Phase 2]
The Phase 2 Nipocalimab trial in adults with active lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-09-19Clinical Trial Update: CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy, in Patients With Refractory Systemic Lupus Erythematosus (GALLOP) [Phase 1]
This Phase 1 trial investigating a CRISPR-edited allogeneic anti-CD19 CAR-T cell therapy for systemic lupus erythematosus has been withdrawn…
-
CLINICAL_TRIALS withdrawal · 2025-05-23Clinical Trial Update: Atacicept in Subjects With Active Lupus Nephritis (COMPASS) [Phase 3]
A Phase 3 trial evaluating atacicept in active lupus nephritis has been withdrawn (COMPASS), with no results reported.
-
CLINICAL_TRIALS withdrawal · 2025-04-24Clinical Trial Update: A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus Erythematosus [Phase 1]
A Phase 1 study evaluating the safety and preliminary efficacy of ATA3219 in systemic lupus erythematosus and lupus nephritis has been withd…
-
CLINICAL_TRIALS withdrawal · 2025-04-20Clinical Trial Update: A Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G [Phase 2]
Phase 2 trial of ADX-097 for IgA nephropathy, lupus nephritis, and C3 glomerulopathy has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-04-06Clinical Trial Update: A Study of TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc) [Phase 1]
A Phase 1 study of TAK-007 in adults with refractory lupus nephritis or refractory systemic sclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-10Clinical Trial Update: A Study of IMPT-514 in Active Refractory Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]
Lyell Immunopharma's IMPT-514 trial in active refractory lupus nephritis and systemic lupus erythematosus has been withdrawn (Phase 1/Phase …
-
CLINICAL_TRIALS withdrawal · 2024-05-13Clinical Trial Update: BAFF Levels and Lupus Nephritis (LN)
The clinical trial investigating BAFF levels in lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-02-02Clinical Trial Update: Pentoxifylline in Lupus Nephritis [Phase 4]
Phase 4 trial of pentoxifylline for lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-11Clinical Trial Update: ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis [Phase 4]
The Phase 4 trial of ACTHAR Gel for membranous lupus nephritis (class V) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-12Clinical Trial Update: A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Lupus Nephritis Previously Enrolled in Study U2970g [Phase 3]
A Phase 3 clinical trial evaluating the safety of retreatment with rituximab in patients with lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis [Phase 3]
The CHABLIS-SC2 Phase 3 trial of subcutaneous blisibimod for systemic lupus erythematosus (with or without nephritis) has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-08-04Clinical Trial Update: The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria [Phase 4]
A Phase 4 clinical trial evaluating calcitriol for systemic lupus erythematosus–associated lupus nephritis with persistent proteinuria has b…
-
CLINICAL_TRIALS withdrawal · 2015-05-14Clinical Trial Update: Open Label Pilot Trial of Rituximab in Lupus Membranous Nephritis [NA]
A open-label pilot trial of rituximab for lupus membranous nephritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-02-27Clinical Trial Update: Clinical Trial Treatment in Lupus Nephritis [Phase 3]
A Phase 3 clinical trial in lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-02-12Clinical Trial Update: Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis [Phase 3]
A Phase 3 trial evaluating tacrolimus sustained-release capsules for induction therapy in lupus nephritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-04-24Clinical Trial Update: Velcade for Proliferative Lupus Nephritis [Phase 4]
A Phase 4 clinical trial evaluating Velcade (bortezomib) for proliferative lupus nephritis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2008-05-29Clinical Trial Update: Steroids in the Maintenance of Remission of Proliferative Lupus Nephritis [Phase 3]
A Phase 3 trial evaluating steroids for maintenance of remission in proliferative lupus nephritis has been withdrawn.
-
EMA withdrawal · 2006-10-13EMA Application withdrawn: Riquent (abetimus) — La Jolla Limited
The EMA withdrew the application for Riquent (abetimus) by La Jolla Limited for lupus nephritis.